Sustained release pharmaceutical preparations and methods for producing the same
AssigneeSidmak Laboratories, Inc.
InventorsDavejibhai Kumbhani, Harish B. Pandya, Hiren Patel
Life of this patent
Estimating the term…
Abstract
An extended release tablet comprising a core including albuterol sulfate and extended release agent; and an extended release coating on the core to provide for sustained release of the albuterol sulfate.
Claims28
An extended release tablet comprising:
- a core including albuterol sulfate and extended release agent;
- and
- an extended release coating associated with the core to provide for sustained release of the albuterol sulfate.
A diffusion controlled tablet for extended release of albuterol sulfate comprising albuterol sulfate in a diffusion controlled formulation structured and arranged to provide an albuterol dissolution profile for a formulation containing 8 mg of albuterol of:
- 40 2nd Hour Not more than 30% 6th Hour 50-75% 10th Hour Not less than 75%.
A diffusion controlled tablet for extended release of albuterol sulfate comprising albuterol sulfate in a diffusion controlled formulation structured and arranged to provide an albuterol dissolution profile for a formulation containing 4 mg of albuterol of:
- 41 2nd Hour Not more than 20% 6th Hour 45-70% 10th Hour Not less than 75%.
A diffusion controlled formulation for extended release of albuterol sulfate comprising albuterol sulfate in a diffusion controlled formulation structured and arranged to provide bioequivalency to an albuterol sulfate osmotic device formulation.
Dependencies are inferred from the claim text.